Automated Immunoassay Technology for Efficient Biomarker Detection

Biofluid-based biomarkers have shown promise in helping to improve diagnostic accuracy, predict disease progression and evaluate responses to therapeutic interventions. Yet, biomarkers for neurodegenerative disorders are often found in concentrations as low as picograms per milliliter. Hence, sensitive, robust and reproducible assays are required to monitor the progression of these disorders. This webinar explores a highly sensitive, automated assay workflow to provide high-quality results for low-abundance biomarkers in serum, plasma and cerebrospinal fluid. Watch this webinar to explore: Detection and measurement of biomarkers in biological fluids A microfluidic automated platform that builds upon existing ELISA principles to improve dynamic range and sensitivity The applications of precision biomarker detection in neurodegenerative disease research